Tag: life sciences

Poor Countries to Urge G-7 Members to Share More Covid-19 Vaccines

Public-health officials and leaders in developing-world countries are expected to press the Group of Seven countries to commit to large donations of Covid-19 vaccines and billions in...

U.S. inflation is still climbing and now higher labor costs are adding to the pressure

Surging U.S. inflation tied to reopening of the economy is supposed to start to fade by the end of the year, but rising wages threaten...

Europe Pushes Alternative to U.S.-Backed Covid-19 Vaccine Patent-Waiver Plan

The European Union is pushing back hard against U.S.-backed calls to temporarily waive intellectual property rights for Covid-19 vaccines, preparing a rival plan that officials...

Developed Countries Lock Up Covid-19 Vaccines Through 2023

The European Union, Canada and other developed countries have signed deals to get hundreds of millions of doses of Covid-19 vaccines and boosters over the...

WHO Seeks More Funding for Covid-19 Vaccines, Endorses Sinovac’s Shot

GENEVA—The World Health Organization called Tuesday for $50 billion in funding from wealthy nations to buy vaccine doses for developing countries, saying that “countless lives”...

Foreign Governments Request Covid-19 Vaccine Doses as U.S. Prepares to Share

Countries such as Pakistan, Afghanistan, Bangladesh and Sri Lanka have petitioned the U.S. for Covid-19 vaccines as the Biden administration prepares to share 80 million...

European Union Approves Pfizer-BioNTech Vaccine for Adolescents

The European Union’s health agency approved the Covid-19 vaccine from Pfizer Inc. and BioNTech SE for children between the ages of 12 and 15 years...

Figs IPO: 5 things to know about the healthcare apparel company before it goes public

Figs Inc., an apparel and lifestyle company for healthcare workers, has filed to take the company public, eight years after the co-founders started the company...

France Suspects Russian Role in Campaign to Discredit Pfizer Vaccine

PARIS—French counterintelligence authorities are investigating whether the Russian government was behind an attempt to pay high-profile health and science bloggers to sow public doubts about...

8 sunscreens dermatologists and skincare pros say you should try

MarketWatch has highlighted these products and services because we think readers will find them useful. We may earn a commission if you buy products through...

India’s Covid-19 Crisis Tests the World’s Back Offices

India’s giant outsourcing firms are facing a two-front challenge: protecting the health of millions of employees as the nation suffers the world’s worst Covid-19 crisis,...

U.S. Will Provide Covid-19 Vaccines to 550,000 South Korean Troops Engaged With U.S. Forces

President Biden said Friday the U.S. will provide Covid-19 vaccines to 550,000 South Korean troops working in close contact with American forces in the region....

Pfizer’s next play: A vaccine maker and pandemic ‘partner’ to governments

Pfizer Inc.’s COVID-19 vaccine is on track to generate a whopping $26 billion in sales this year, making it the drug maker’s top-selling drug and...

Opinion: Biotech companies are trying to solve stubborn illnesses using ‘drugs from bugs’

Poor germs. They just can’t catch a break. Many people, not only germaphobes, spend lots of energy trying to avoid germs like, well, the plague....

New York City sets goal to reopen fully on July 1: De Blasio

Mayor Bill de Blasio announced Thursday morning that New York City will set a goal to ‘fully reopen’ on July 1, citing the city’s strong...

The resurgent U.S. economy grew 6.4% in first quarter and even faster growth lies ahead

The numbers: The U.S. economy charged ahead in the first three months of the year thanks to more Americans getting vaccinated, fewer people catching the...

The pandemic’s differing earnings effects will be on display with tech, airline reports

The first big week of earnings season will kick off with a study in contrasts. The tech and airline sectors feature prominently on the earnings...

Tech shares rise but Dow under pressure as U.S. pauses Johnson & Johnson COVID vaccine rollout

U.S. stocks were trading mixed Tuesday morning after U.S. public-health agencies requested a temporary halt in the use of Johnson & Johnson’s one-shot COVID vaccine...

How to pay for healthcare costs in retirement

As retirement risks go, it’s one of the more impossible to manage and mitigate. For years now, firms in the financial services industry, as well...

Oil prices fall as U.S. data show hefty rise in gasoline supplies

Oil prices headed lower on Wednesday, with gasoline futures leading the losses in the sector as traders parsed U.S. government data showing a more-than-3-million-barrel decline...

U.S. COVID vaccine program speeds up to about 3 million doses a day in the past week

The U.S. COVID-19 vaccine program continues to kick into high gear, setting a record Saturday of more than four million doses administered, although experts continue...

Here are the stocks that could benefit from $4 trillion of infrastructure spending, according to Bank of America

President Joe Biden is due to present his infrastructure spending plan on Wednesday, the opening salvo in getting legislation through Congress to fix crumbling roads...

What you need to know about COVID-19 vaccine passports — and the ‘double privilege’ dilemma they raise for society

Neil Schwartzman is used to getting vaccines in order to travel to exotic parts of the world such as the Great Rift Valley of Kenya...

These are the stocks for playing Biden’s infrastructure push, analysts say

President Joe Biden’s big speech on infrastructure is slated to come on Wednesday as he visits Pittsburgh. Analysts have been thinking about his push for...

Dow clings to gain, but tech stocks slide while Beige Book shows only modest economic uptick

U.S. stock benchmarks mostly were lower Wednesday afternoon, as technology shares weighed down the S&P 500 and Nasdaq Composite, after bond yields spiked and weaker-than-expected...